Kuala Lumpur (PRWEB) April 4, 2006
Synamatix today announced that Washington University Genome Sequencing Center (WUGSC) has licensed SynaBASE™ and associated applications for use in high-throughput genomic analysis for internal research projects. The Center will also apply selected Synamatix applications towards enhancing quality control of data from newly sequenced genomes.
The SynaBASE database platform is a novel approach towards enhancing the scalability, sensitivity and performance of genomics research without necessarily requiring incremental utilisation of specialist computer hardware. Dr. Jarret Glasscock, who heads the computational biology group at WUGSC stated, “We are excited about the potential of applying SynaBASE towards our larger scale tasks as well as addressing some novel areas which take advantage of the SynaBASE approach.”
Dr. Arif Anwar, Vice President of Synamatix said, “It is particularly encouraging to welcome WUGSC as a partner and user as they have identified numerous additional applications for the SynaBASE platform. We are looking forward to developing a mutually beneficial partnership which can deliver tangible advances in genome research.”
Synamatix’s high-performance applications and SynaBASE, its unique structured network database platform, have been licensed for onsite use by WUGSC but can also be accessed online via My Genomics Resource Centre (MGRC) at http://www.mgrc.com.my, a newly established bioinformatics applications platform.
About Washington University Genome Sequencing Center
The Genome Sequencing Center is a world-leader in the generation and public dissemination of high-quality genomic sequence. We seek to advance the states of science and medicine by (1) providing sequence data with ever-improving economy, (2) developing and refining the general theories and practices of DNA sequencing, (3) providing value-added biologically and clinically-relevant sequence analysis, and (4) fostering public understanding of science through various educational and outreach efforts.
The fundamental technology underlying Synamatix R&D is the proprietary “SynaBASE” platform. SynaBASE finds all patterns in data and stores them in a network structure. Applications built upon this database platform exhibit very significant improvements in analysis scalability, sensitivity and performance. Synamatix is a privately held bioinformatics company whose primary activities are based upon ongoing R&D related to its core technology and support of its user base in the USA, Europe, Asia and Australia.